ICTS Success Stories
Leveraging ICTS support (2015 CTRFP Funding Program Pilot award and a KL2 Career Development award) with IPH PH3 Public Health Cubed funding, Rupa Patel, MD MPH (Infectious Diseases) has developed a Missouri HIV PrEP Implementation Tool Kit and guidance to resources for consumers and care providers. READ MORE >>
Eric Lenze, MD (Psychiatry) has moved findings from multiple JIT projects and funding through a 2015 CTRFP Funding Program Pilot award to direct multicenter clinical trials assisted by the NCATS Trial Innovation Network. Studies are designed to improve cognition, depression and rehabilitation in older adults using behavioral and pharmacologic interventions. READ MORE>>
Patty Cavazos-Rehg, PhD (Psychiatry), a 2007-2009 KL2 Career Development Scholar alumna, established her independent career understanding how policy and social media shape risky health behaviors amongst youth through ICTS support. She now directs thePostdoctoral Mentored Training Program in Clinical Investigation (MTPCI) within the ICTS Clinical Research Training Center (CRTC). READ MORE>>
Nancy Tye-Murray, PhD (Otolaryngology) used CTRFP funding and an ICTS-supported LEAP Challenge grant in 2015 to identify markets and plug into the StL entrepreneurial community to launch the clEAR start-up. clEAR is an Internet business that provides customized auditory training exercises for people with hearing loss through engaging computer games. READ MORE>>
Peter Nagele, MD, was enrolled in the Postdoctoral Mentored Training Program in Clinical Investigation (MTPCI) as an instructor in 2007, promoted to Assistant Professor in July 2008, and subsequently developed into an independent investigator in 2015 (R01). In 2010, he was funded under the K23 program through the National Institute of General Medical Sciences. Dr. Nagele, an Associate Professor of Anesthesiology, now serves as Chief of Trauma Anesthesiology at Barnes-Jewish Hospital. Additionally, he now serves as a mentor for scholars and trainees in various ICTS education programs. READ MORE>>
Ana Maria Arbelaez, MD, MSCI (Pediatrics), used the Mentored Training Program in Clinical Investigation (MTPCI) and the KL2 Scholar programs on her career pathway to independent investigator status. She now serves as Associate Director of the TL1 Predoctoral Interdisciplinary Training Program (ICTS TL1 grant) and has recently been appointed as interim Chief of the Pediatric Endocrinology and Diabetes Division. READ MORE>>
The Dissemination & Implementation Research Core (DIRC), directed by Enola Proctor, PhD, MSW, has contributed locally and nationally in dissemination and implementation science and in training. The core was established to help investigators "design for dissemination" by moving evidence-based practices to real-world use. Learn how the core and its director speed the adoption and delivery of routine medical care and help reduce disparities in health care delivery. Discover D&I Toolkit Resources which were developed for DIRC consultations to impact common design issues and read more about national efforts driven by DIRC leaders on the CTSA Central Dissemination-Implementation and Knowledge Transfer Workgroup (part of the NCATS Collaboration/Engagement Domain Task Force). READ MORE>>
Congratulations to national leader Methodius Tuuli, MD, who was recently recognized with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. Awards exemplify exceptional publications that contribute to the knowledge of health and disease resulting from national investment in clinical and translational research. VIDEO LINK >>
2012 SPIRiT Pilot awardee, Daniel Ory, MD, moved a newly approved FDA-therapy to Phase 2b/3 clinical trials for Niemann-Pick type C1 (NPC1) disease. The research was featured in an NCATS Information release highlighting the Therapeutics for Rare and Neglected Diseases (TRND) Program and a recent paper describing the process for fostering collaborative research for rare genetic diseases modeling the NPC1 experience.
For a timeline of translational science events, READ MORE >>
Leveraging 2011 Pilot funding and a 2016 JIT award to use services from the Regulatory Support Center (RSC) , Fumihiko Urano, MD, PhD, secured IND approval for the use of dantrolene sodium in treatment of Wolfram Syndrome treatment. The first patients were enrolled in the Dantrolene Clinical Trial -- NCT02829268 in Feb 2017.
Learn more about The Wolfram Syndrome International Registry , a member of the NCATS Global Rare Disease Registry program.
See the translational science timeline for the Wolfram Syndrome project, READ MORE>>